L
Lixte Biotechnology Holdings D
D
LIXT
2.35000
USD
-0.10
(-4.08%)
مغلق
حجم التداول
109
الربح لكل سهم
0
العائد الربحي
-
P/E
-1
حجم السوق
5,285,832
المقالات
العنوان: Lixte Biotechnology Holdings
القطاع: Healthcare
الصناعة: Biotechnology
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. Itfocuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.